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Introduction 
Many of the cloned vertebrate nuclear receptors have 
been extensively studied in vitro in transfected cultured 
cells. Unfortunately, this approach isfarfrom being physio- 
logical (e.g., the amount of receptor may greatly exceed 
the normal cellular amount) and does not necessarily re- 
flect what is occurring in vivo. Ligand “manipulation” may 
provide some clues about functions of the cognate recep- 
tor. However, the actual involvement of a particular recep- 
tor in the known functions of its ligand needs to be demon- 
strated in animals in which the functions of the receptor 
have been abrogated by genetic means. This is particu- 
larly true in cases when several receptors bind the same 
ligand or when the ligand also interacts with other proteins 
(e.g., cellular retinoic acid-binding proteins [CRABPs] in 
the case of retinoic acid [RA]). Genetic studies are even 
more crucial for assigning functions to orphan receptors. 
Targeted disruption (knockout) via homologous recombi- 
nation has recently been used to generate mice lacking 
receptors (Table 1). Expression of dominant negative re- 
ceptors or antisense mRNA has also been employed. To- 
gether with some nuclear receptor mutations associated 
with pathological conditions, knockouts have led to signifi- 
cant advances in our knowledge of the physiological func- 
tions of several nuclear receptors, but have also raised 
unexpected problems. These studies and their implica- 
tions are summarized and discussed here except those 
concerning steroid hormone receptors (see Beato et al., 
1995 [this issue of Cell]). 
Orphan Receptors 
Function of FTZ-Fl 
The FTZ-Fl gene protein (also known as SF1 or Ad4BP) 
binds to promoter regions of several steroidogenic en- 
zymes (for references see Sadovsky et al., 1995) and of 
theanti-Mijllerian hormone(AMH; Shen et al., 1994). Com- 
parison of the expression pattern of FTZ-Fl and AMH in 
the embryonic gonad strongly suggests that FTZ-Fl could 
be a key regulator of AMH expression, and thus control 
the differentiation of the male genital apparatus (Shen et 
al., 1994). 
FTZ-Fl null mutants lack gonads and adrenals and die 
during the first days of life, probably owing to the absence 
of adrenal function since they can be rescued by cortico- 
steroids administration (Luo et al., 1994,1995a; Sadovsky 
et al., 1995; Shinoda et al., 1995). These mice also lack 
theventromedial hypothalamicnucleus(Ikedaetal., 1995; 
Shinoda et al., 1995). In addition, gonadotropic markers 
(luteinizing hormone, follicle-stimulating hormone, and the 
gonadotropin-releasing hormone [GnRH] receptor) could 
not be detected in the pituitary (Ingraham et al., 1994), 
but were induced by GnRH treatment (Ikeda et al., 1995). 
As GnRH hypothalamic neurons are present in FTZ-Fl 
mutants, the abnormal pattern of gene expression in go- 
nadotropic cells probably reflects an impaired GnRH re- 
lease, which might be caused by an abnormal or absence 
of interaction between the ventromedial hypothalamic nu- 
cleus and the GnRH neurons (Ikeda et al., 1995). Thus, 
FTZ-Fl appears to be critical for the development, func- 
tion, or both of the hypothalamic-pituitary-gonadal axis. 
Ironically, the null mutants cannot be used to assess 
FTZ-Fl function in either the control of steroidogenic en- 
zyme or AMH expression, as tissues in which these regula- 
tions take place are not formed. 
Function of NGFI-BlNURR77 
Nerve growth factor-induced receptor NGFI-B is an imme- 
diate-early protein whose expression is induced by a vari- 
ety of stimuli. NGFI-B may be involved in the control 
of the hypothalamic-pituitary-adrenocortical axis, as 
NGFI-B transcripts are strongly induced by stress in the 
adrenal cortex and in the paraventricular hypothalamic 
nucleus (for references see Crawford et al., 1995). To- 
gether with FTZ-Fl, NGFI-B has also been implicated in 
the control of steroidogenic enzyme expression in adrenal 
glands (for references see Crawford et al., 1995). NGFI-B 
might also act in the control of activation-induced 
apoptosis of thymocytes and T cell hybridomas, since 
NGFI-B is rapidly and strongly induced after activation of 
immature thymocytes and since expression of a“dominant 
negative” NGFI-B or NGFI-B antisense transcripts pre- 
vents activation-induced apoptosis of T cells (Liu et al., 
1994; Woronicz et al., 1994). It was therefore a surprise 
that NGFI-B null mutants display no detectable defect, 
with respect to both T cell apoptosis and function of the 
hypothalamic-pituitary-adrenocortical axis (Lee et al., 
1995a; Crawford et al., 1995). The apparent discrepancy 
between the normal phenotype of the NGFI-B null mice 
and the functions postulated above for NGFI-B most prob- 
ably reflects functional redundancy (compensation) by 
closely related receptors(NURR1 and NGFI-6~; see Craw- 
ford et al., 1995). The absence of an apoptosis phenotype 
in NGFI-B mutant thymocytes indicates that the dominant 
negative and antisense approaches lack specificity and 
are prone to unexpected artefacts, as their effects cannot 
be attributed to the loss of function of NGFI-B only. 
Function of DAXl 
DAXl is an unusual member of the nuclear receptor family, 
since it contains a nuclear receptor-like ligand-binding do- 
main (LBD), but an unrelated DNA-binding domain (DBD). 
Loss-of-function mutations of DAXl have been identified 
as the genetic basis of X-linked adrenal hypoplasia con- 
genita and X-linked hypogonadotropic hypogonadism, 
characterized by structural abnormalities of the adrenal 
glands and gonads, resulting in impaired steroidogenesis 
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Table 1. Viability of Nuclear Receptor Knockout Mice 
Mutated Receptor(s) Lethality in Utero Perinatal Lethality 
Reduced Postnatal 
Viability 
Normal 
Viability References 
Orphans 
FTZ-FI 
NGFI-B 
HNM 
COUP-TF-I 
COUP-TF-II 
PPARu 
TRs 
TW 
RXRs 
RXRa 
RXR6 
RARs 
RARa 
RAR6 
RARy 
RARal 
+ 
+a 
RAR62 + 
RARy2 + 
RAR double mutants 
RARoiy 
RARuly 
RARal62 
RARullf32 
+= 
+ 
+ 
+ 
f 
+a 
+a 
+a 
+ Luo et al., 1994; 
Sadovsky et al., 1995; 
Shinoda et al., 1995 
+ Lee et al., 1995a 
Chen et al., 1994 
Qiu et al., 1995 
Qiu et al., 1995 
Lee et al., 1995b 
+a 
+a 
+a 
+a 
+ 
+a 
+ 
Forrest et al., 1995 
Sucov et al., 1994; 
Kastner et al., 1994 
Kastner et al., 1996 
Lufkin et al., 1993 
Luo et al., 1995b 
Lohnes et al., 1993 
Lufkin et al., 1993; 
Li et al., 1993 
Mendelsohn et al., 1994b 
Lohnes et al., 1993 
Lohnes et al., 1994 
Lohnes et al., 1994 
Lohnes et al., 1994 
Lohnes et al., 1994 
Lohnes et al., 1994 
a This phenotype is only partially penetrant 
(Zanaria et al., 1994; Muscatelli et al., 1994). It is intriguing 
that the DAXl and FTZ-Fl mutations affect the same tis- 
sues, raising the question whether these receptors may 
belong to the same regulatory pathway. Interestingly, a 
putative FTZ-Fl response element has been found in the 
Daxl promoter (Burris et al., 1995). 
Function of HMF4 
Hepatocyte nuclear factor 4 (HNF4) binds to response ele- 
ments present in several liver-specific genes (for refer- 
ences see Chen et al., 1994). ‘Together with its restricted 
expression in liver, intestine, and kidney, this suggests an 
important role for HNF4 in the mediation of tissue-specific 
gene expression in these organs. HNM mutants die at 
approximately 8.5 days postcoitum (dpc) (Chen et al., 
1994) and exhibit extensive cell death in the ectoderm 
at 6.5 dpc. Gastrulation and mesoderm formation appear 
delayed by 24 hr and are greatly impaired. The underlying 
mechanisms are unknown, but the primary defect is likely 
to reside in the visceral endoderm, which selectively ex- 
presses HNF4 at early stages. Chen et al. (1994) have 
suggested that ectodermal cell death and subsequent 
morphogenetic defects may reflect the impaired produc- 
tion by the visceral endoderm of factors necessary for sur- 
vival of ectodermal cells. Owing to this early embryonic 
lethality, the HNM mutation failed to produce an in vivo 
model for the study of HNM function in liver-specific gene 
expression. 
Function of COUP-TFs 
Chicken ovalbumin upstream promoter transcription fac- 
tors (COUP-TFs)(COUP-TF-I and COUP-TF-II, also known 
as Arp-1; see Qiu et al., 1995) are highly conserved in 
evolution, as their DBD and putative LBD amino acid se- 
quences are almost identical to those of their Drosophila 
homolog, Seven-up. This strong evolutibnary pressure 
suggests that COUP-TFs probably perform important 
functions. Both COUP-TF-I and COUP-TF-II have been 
mutated in the mouse, and preliminary results indicate 
that both genes are essential, since COUP-TF-I mutants 
die perinatally, and COUP-TF-II mutants die in utero (see 
Qiu et al., 1995). Thus, despite extensive overlap in their 
patterns of expression and a high sequence similarity, 
COUP-TFs perform some important nonredundant func- 
tions 
Function of WARS 
In transfected cells, peroxisome proliferator-activated re- 
ceptors a, 8, and y (PPARa, PPAR8, and PPARy) are 
activated by a variety of fatty acids and several synthetic 
compounds that induce peroxisome proliferation in the 
liver and hepatocarcinogenesis (reviewed by Green and 
Wahli, 1994). As heterodimers with retinoid X receptors 
(RXRs), PPARs have been broadly implicated in the con- 
trol of lipid metabolism, since putative PPAR response 
elements have been characterized in the promoter regions 
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of several genes encoding enzymes involved in fatty acid 
catabolism (p- and w-oxidation). In addition, the PPARyP 
isoform was shown to induce adipocitic differentiation of 
preadipocyte cell lines (Tontonoz et al., 1995). 
So far, only PPARa null mutants have been reported 
(Lee et al., 1995b). They are phenotypically normal, but 
appear refractory to the action of peroxisome proliferators. 
Hepatomegaly, peroxisome proliferation, and induction of 
enzymes involved in fatty acid catabolism (e.g., acetylco- 
enzyme A oxydase, bifunctional enzyme) were not ob- 
served. Thus, PPARa mediates the response to peroxi- 
some proliferators. Although these observations support 
the idea that PPARa is involved in the control of lipid catab- 
olism, the “normal” physiological function of PPARa re- 
mains uncertain, since the basal level of expression of 
most of the above enzymes was not affected in the mu- 
tants. However, even though it was not emphasized by 
Lee et al. (1995b), the basal expression of bifunctional 
enzyme appeared to be markedly reduced. It will therefore 
be interesting to investigate whether B-oxydation is im- 
paired in these animals. 
Function of Thyroid Hormone Receptors 
Studies of thyroid hormone-deficient animals and human 
nutritional iodine deficiency have demonstrated a key ro!e 
for thyroid hormones in development of the central ner- 
vous system, postnatal maturation of the myocardium, and 
pituitary-thyroid axis homeostasis. There are two thyroid 
hormone receptor (TR) genes, TRa and TRB. Mutations 
in the TRP gene have consistently been found in patients 
with the dominantly inherited general resistance to thyroid 
hormone (GRTH) syndrome, characterized by high circu- 
lating levels of thyroid hormones and thyroid-stimulating 
hormone and by symptoms similar to those arising from 
thyroid hormone deficiency (e.g., hearing defects, mental 
retardation, learning disabilities, and emotional distur- 
bance). These mutations, which always correspond to 
point mutations located in the LBD, decrease or abolish 
ligand binding, but not heterodimerisation with RXR nor 
DNA binding (Collingwood et al., 1994, and references 
therein). Mutant receptors act as dominant negatives and 
inhibit T3-dependent activation by wild-type TR in vitro. 
GRTH patients exhibit several other defects, notably vari- 
ous congenital skeletal malformations, that cannot be ex- 
plained on the basisof thyroid hormone deprivation (Refet- 
off, 1982). Thus, a dominant negative TRB might also 
interfere with events not normally mediated by TRs, possi- 
bly via RXR titration. In contrast, no TRa mutation has 
been found in GRTH patients. Thus, the absence of TRa 
may lead only to subtle defects, or, alternatively, a muta- 
tion in the TRa gene may be lethal. 
TRB null mutant mice display the syndrome of pituitary 
resistance to thyroid hormone and impaired hearing (For- 
rest et al., 1995). Interestingly, deafness has been associ- 
ated with various human thyroid disorders. 
Function of the Vitamin D Receptor 
No knockout of the vitamin D receptor (VDR) gene has 
been reported yet, but VDR mutations are associated with 
hypocalcaemic vitamin D-resistant rickets in humans. 
Hypocalcaemic vitamin D-resistant rickets is a recessive 
disease characterized by high levels of 1,25dihy- 
droxyvitamin Ds, severe rickets, hypocalcaemia, second- 
ary hyperparathyroidism, and total absence of hair in se- 
vere cases. Homozygous point mutations in the VDR gene 
have been identified in several kindreds (Hughes et al., 
1988; Kristjansson et al., 1993; Wiese et al., 1993). These 
mutations fall into two major categories: mutations in the 
DBD, abrogating DNA binding, and nonsense mutations 
resulting in loss of ligand binding. It is unclear why domi- 
nant negative mutations similar to those of TRB have not 
been found for VDR. One possibility would be that TR, 
but not VDR, dominant negative alleles are overexpressed 
relative to wild-type alleles. 
A strong association has been found between appar- 
ently functional VDR allelic variants, a decreased bone 
mineral density, and the rate of bone mineral density 
change in relation to calcium intake (Morrison et al., 1994). 
How these allelic variants affect bone mineralization is 
unknown, but there are nucleotide changes in their 3’ un- 
translated region that appear to be associated with a lower 
mRNA stability (Morrison et al., 1994). 
Function of Retinoid Receptors 
Until recently, the physiological functions of retinoids were 
mainly inferred from studies on vitamin A-deficient (VAD) 
animals and, rather paradoxically, from the defects 
caused by administration of pharmacological doses of RA 
(reviewed by Means and Gudas, 1995). VAD studies have 
shown that vitamin A (retinol) is required during pre- and 
postnatal development and in adult life. After birth, retinol 
is indispensable for survival, growth, reproduction, and 
vision and also for the maintenance of numerous tissues. 
Widespread squamous metaplasia of various epithelia 
and degeneration of seminiferous tubules and photore- 
ceptors are hallmarks of the postnatal VAD syndrome, and 
RA can prevent or reverse the effects of a postnatal VAD 
diet, with the exception of night blindness and photorecep- 
tor degeneration (for references see Chambon, 1994). In- 
terestingly, conceptuses of VAD dams exhibit a large num- 
ber of congenital malformations (i.e., the fetal VAD 
syndrome; Figure I; for references see Lohnes et al., 
1994; Mendelsohn et al., 1994a). 
Two families of retinoid nuclear receptors have been 
characterized (Leid et al., 1992). Retinoic acid receptors 
(RARs) (types a, p, and y and their isoforms al, a2, PI 
to 04, and yl and ~2) are activated by all-trans and 9-cis 
RA, whereas RXRs (types a, p, and y and their isoforms) 
are activated by 9-cis RA only. The complexity of retinoid 
signaling is further increased by the fact that, at least in 
vitro, RARs bind to their cognate response elements as 
heterodimers with RXRs. Moreover, RXRs, which can also 
bind in vitro to certain DNA elements as homodimers, are 
heterodimeric partners for a number of nuclear receptors, 
such as TRs, VDR, PPARs, and NGFI-B (reviewed by 
Mangelsdorf and Evans, 1995 [this issue of Cc/o). 
Null mutations of RARa, RARfi, or RARy, as well as 
isoform-specific knockouts of RARal, RARp2/(34, and 
RARy2, have been generated (Tables 1 and 2). Mice lack- 
ing RARB, RARal, RARP2, or RARyP appear normal. In 
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Abnormalities 
of the fetal VAD syndrome 
genotype of RAR mutants 
exhibiting similar 
congenital abnormalities 
Respiratory tract defects 
l Agenic or hypoplastic left lung’ 
l Hypoplastic right lung’ 
l Lack of oesophago-tracheal septum’ 
a/p2 # 
a/pa # 
al@ 2 + odj.52 # 
Thinner “spongy” myocardium ctfy (mild) 
Heart outflow tract and aortic arch derivative 
abnormalities 
l Persistent truncus arteriosus (NCC) 
l Dextroposed aorta (NCC) 
l High ventricular septal defect* 
l Abnormalities of great arteries derived 
from aortic arches (NCC) 
al@2 + oJj32 #, cdy # 
al /p2, al /a2+l-ly, & 
all62 + a/p2 #, alla2+l-/y -3 cd-f # 
all!32 #, alp2 #. nllcx2”ly-t a&# 
Diaphragmatic hernia * 432 
Ureter abnormalities 
l Agenesis’ 
l Ectopia’ 
cW2, alj32,a/y# 
at@2, u/B2 
Genital tract abnormalities 
- Female * Agenesis of the the oviduct and uterus * 
- Total 
- Partial 
l Agenesis of cranial vagina’ 
- Male l Agenesis or dysplasia of vas deferens’ 
l Agenesis of seminal vesicles* 
a/p2 # 
nl@2 #, afy # 
al@2 + a/j32 #, IYfy # 
atla2+i-ly + u/y # 
alr# 
Ocular abnormalities 
l Coloboma of the retina* 
l Coloboma of the optic nerve’ 
l Retrolenticular membrane* (NCC) 
l Unfused eyelids’ (NCC) 
l Small conjonctival sac’ (NCC) 
l Abnormal cornea1 stroma (NCC) 
l Absence of anterior chamber’ (NCC) 
l Abnormal lens fibers 
l Agenesis of cornea, conjunctiva 
and eyelids’ (NCC) 
l Shortening of ventral retina and 
ventral rotation of the lens 
l Prenatal retinal dysplasia 
Figure 1. Almost Ail the Abnormalities of the 
Fetal VAD Syndrome Are Found in One or Sev- 
eral Combinations of RARa (Total or al), 
RARf32, or RARy Double Mutants 
Note that most of the abnormalities found in the 
a/T mutants are absent in al/T and alla2+‘+/T 
mutants. Asterisks indicate abnormalities that 
correspond to ontogenetic arrests. The abbre- 
viation NCC indicates abnormalities attributed 
to faulty migration, differentiation, proliferation, 
or apoptosis of NCCs. A number sign indicates 
an abnormality that is completely penetrant. 
The arrow denotes an increase from partial to 
full penetrance of the defect. For further details 
see Lohnes et al. (1994) and Mendelsohn et 
al. (1994a). 
contrast, RARa or RARy null mutants (i.e., all a or y iso- 
forms disrupted) display some of the defects of the postna- 
tal VAD syndrome that can be cured or prevented by RA 
administration, including poor viability, growth deficiency, 
and male sterility. These mutants also exhibit some con- 
genital malformations (Table Z), which, however, are con- 
fined to a small subset of the tissues expressing these 
receptors. RAR double null mutants have been generated 
to test for a possible functional redundancy in the RAR 
family (Table 1; Figures 1 and 2). In contrast with RAR 
single mutants, most of the double mutants exhibit a dra- 
matically reduced viability (Table 1). Furthermore, almost 
Table 2. Postnatal Manifestations of RAR and RXR Single Knockouts 
Genotype Abnormalities References 
RARal None 
RARa Decreased viability, growth deficiency, male sterility 
(degeneration of seminiferous epithelium); congenital 
malformations: webbed digits, homeotic transforma- 
tions, and malformations of cervical vertebrae” 
RARTP None 
RARy Decreased viability, growth deficiency, male sterility 
(squamous metaplasia of seminal vesicle and pros- 
tate gland epithelia); congenital malformations: 
webbed digits, homeotic transformations, and malfor- 
mations of cervical vertebrae, fusion of trachea rings, 
agenesis of Harderian glands 
RARbP None reported 
RARf3 None reported 
RXRa+‘- Growth deficiency 
RXR6 Male sterility (defective spermiogenesis) 
a Low penetrance and expressivity. 
Li et al., 1993; Lufkin et al., 1993 
Lufkin et al., 1993; Lohnes et al., 1994 
Lohnes et al., 1993 
Lohnes et al., 1993 
Mendelsohn et al., 1994b 
Luo et al., 1995b 
Kastner et al., 1994 
Kastner et al., 1996 
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Congenital Abnormalities not associated 
with the fetal VAD syndrome 
RAR mutant genotype 
Exencephaly’ 
Skeletal abnormalities 
Agenesis or malformations of crania-facial skeletal 
elements (NCC) 
orir 
all~Q+~-/y# (mild), a/y # 
Homeotic transformations and malformations of 
cervical vertebrae 
Limb bone agenesis and malformations 
Appearance of atavistic skeletal structures 
a, y+ ally#, aJy#, a/p2 #, ply 
a/u# 
l Pila antotica (NCC) ally#, aly# 
l Pterygoquadrate cartilage (NCC) alla2+l-ly + cdy #, al/P2 + a&2, ply 
Ocular abnormalities 
Corneal-lenticular stalk* al la2+1-ly, u/y 
Lens agenesis’ a/u 
Post natal retinal dysplasia WY2 
Glandular abnormalities 
Harderian, sublingual, submandibular, glandular 
agenesis and dysplasia 
1: ally, 04 021~ 
Figure 2. Congenital Malformations Absent in 
the Fetal VAD Syndrome Are Exhibited by 
RARa, RARP2, or RARy Singleand Double Mu- 
tants 
Asterisks indicate abnormalities that corre- 
spond to ontogenetic arrests. The abbreviation 
NCC indicates abnormalities attributed to 
faulty migration, differentiation, proliferation, 
or apoptosis of NCCs. A number sign indicates 
an abnormality that is combletely penetrant. 
The arrow denotes an increase from partial to 
full penetrance of the defect. For further details 
see Lohnes et al. (1994) and Mendelsohn et 
al. (1994a). 
Thymus, thyroid, parathyroid gland hypoplasia and 
ectopia (NCC) 
allp2, v-92, alla2+i-ly, or/u 
Other abnormalities 
Webbed digits a, y, f32/y+‘-, a+/-@2 
Abnormal cartilages (thyroid, arytenoid, cricoid, 
bronchial and/or tracheal rings) 
Kidney agenesis or hypoplasia’ 
Anal canal agenesis 
allB2, c(/B2 #, oJy # 
a02 
all of the fetal VAD syndrome malformations are recapitu- 
lated in the different RAR double mutants (Figure 1). These 
findingsdemonstrate that RA istheactivevitaminAderiva- 
tive during development and that the effects of vitamin A 
are mediated by RARs. RAR double mutant fetuses also 
exhibit numerous abnormalities not found in VAD fetuses 
(Figure 2), which most probably reflects the difficulty to 
achieve, bydietarydeprivation,astateofsevereVADcom- 
patible with pregnancy. Interestingly, in contrast with this 
crucial role of RARs in transducing the RA signal, CRABPI 
and CRABPII are not critically involved in these processes, 
as CRABPKRABPII double null mutant mice are essen- 
tially normal (Lampron et al., 1995). 
RARs and the Neural Crest 
Malformations of most of the structures derived from cra- 
nial and cardiac mesectoderm (mesenchymal neural 
crest) were observed in RAR double mutants (Figures 1 
and 2; Lohnes et al., 1994; Mendelsohn et al., 1994a), 
notably in RARaly mutant mice. However, the first pharyn- 
geal arch skeletal elements, which are derived from caudal 
midbrain and rostra1 hindbrain levels (i.e., rhombomeres 
1 and 2) were intact or only mildly affected (Lohnes et al., 
1994). Interestingly, the first arch neural crest cells (NCCs) 
appear to be embodied with a ground state morphogenetic 
program, which is also present in the second pharyngeal 
arch, where it is respecified by expression of Hoxa-2 (Mark 
et al., 1995, and references therein). Frontotiasal mesec- 
todermal cells are also embodied with a similar program 
(Noden, 1983). Thus, the realization of at least part of the 
first arch ground state program does not require RA, 
whereas its modification both in the frontonasal and sec- 
ond arch mesectoderm involves RA-dependent pro- 
cesses. Since NCCs appeared with the emergence of ver- 
tebrates (Gans and Northcutt, 1983), RARs may have 
evolved to fulfil functions necessary for the development 
of mesenchymal NCC-derived structures. In this respect, 
it will be interesting to characterize the RAR that may be 
present in prochordates (e.g., amphioxus), since NCC are 
lacking in these immediate ancestors to vertebrates. Simi- 
larly, it is noteworthythat atavistic reptilian mesectodermal 
structures are generated in RAR mutant mice, namely, a 
pterygoquadrate cartilage (reptilian upper jaw cartilage) 
and a pila antotica (a skeletal element that, in reptiles, 
separates the trigeminal ganglion from the brain). These 
findings suggest that the RA signal has been used during 
evolution to modify ancestral developmental programs in 
the mesectoderm (see Lohnes et al., 1994; Mark et al., 
1995). 
RARs and Axial Patterning 
RARy and (to a much lesser extent) RARa single mutants 
show homeotic transformations and malformations of ver- 
tebrae, thus firmly establishing that RA plays an important 
role in the patterning of the main body anteroposterior axis 
(Lohnes et al., 1993, 1994). The penetrance and expres- 
sivity of these defects increase in a graded manner with 
subsequent loss of RARal and RARa2 alleles from the 
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RARy null background (Figure 2; Lohnes et al., 1994). 
RAF@2 also appears to play a role in axial patterning, since 
RARalf32 (but not RARa) mutants display a high frequency 
of anterior transformations of the sixth and seventh verte- 
brae (Lohnes et al., 1994). These transformations, which 
correspond to almost exclusively anteriorisations, are re- 
stricted to the cervical region and probably arise through 
altered expression of some 3’Hox genes: some of them 
are similar to certain Hox loss-of-function transformations 
(Lohnes et al., 1994, and references therein); RA response 
elements that are functional in vivo are present in the pro- 
moter region of some Hox genes (Studer et al., 1994, and 
references therein; Frasch et al., 1995, and references 
therein); Hox gene expression was shown to be controlled 
by RA in embryonal carcinoma (EC) cells (Mavilio, 1993, 
and references therein). Why only cervical vertebrae are 
transformed in RAR single and double mutants is unclear. 
It may indicate that only the expression of some 3’ Hox 
paralogs, which specifythe identitiesof anteriorvertebrae, 
is critically controlled by RA, as suggested by the preferen- 
tial RA induction of 3’Hoxgenes in EC cells(Mavilio, 1993). 
It is also unclear why the main body axial patterning de- 
fects present in RAR double mutants are milder than ex- 
pected from RA excess experiments (for further discus- 
sion of these points, see Conlon, 1995). The generation 
of RARa/(Yy triple mutants may further define the role of 
retinoid receptors in patterning of the main body antero- 
posterior axis. 
RARs and Limb Morphogenesis 
A role for RARs in limb formation, patterning, and growth 
has been suggested by teratogenic experiments, as sys- 
temic administration of excess RA can induce extra limb 
formation (Rutledge et al., 1994), and topical application 
of RA can mimic the effect of the zone of polarizing activity 
(ZPA) on anteroposterior limb patterning (reviewed by 
Tickle and Eichele, 1994). RARaly mutants display limb 
malformations, demonstrating, at the least, that RA is in- 
dispensable for limb morphogenesis. The majority of the 
forelimb defects in RARaly mutants involve the loss of 
anterior skeletal elements. This phenotype can be inter- 
preted as loss of one of the functions of the wild-type ZPA, 
which is to promote the proliferation of limb bud mesen- 
thyme (Lohnes et al., 1994, and references therein; Con- 
Ion, 1995, and references therein). However, RAR mutant 
limbs all show a clear anteroposterior asymmetry, sug- 
gesting that the “polarizing” activity of their ZPA is essen- 
tially preserved. Since RARf3 is normally present in a re- 
gion of the limb bud that overlaps with the ZPA, the 
possibility remains that inactivation of all three RARs might 
result in more dramatic effects on limb patterning and 
might even affect limb formation. 
Role of RARs in Eye Development 
Warkany and Schraffenberger (1946) reported half a cen- 
tury ago that the developing eye is the most sensitive organ 
to vitamin A deprivation. The spectrum of VAD-induced 
ocular malformations is almost fully recapitulated in RAR 
double null mutants (Figure 1). Thus, RA is clearly the 
vitamin A derivative required for eye morphogenesis, and 
RARs mediate its effects. These studies also demonstrate 
that distinct RARs are required at several steps of eye 
morphogenesis as well as in retinal histogenesis (Figures 
1 and 2). Interestingly, in the absence of RARs some ocular 
structures undergo aberrant differentiation (i.e., the cor- 
neal epithelium keratinizes in RARaly mutants, whereas 
the primary vitreous bodychondrifies in RARf32/y mutants; 
Lohnes et al., 1994). 
Role of RARs in Reproduction 
It has been claimed that retinol plays a unique role in sper- 
matogenesis, as VAD-induced testis degeneration could 
not be reversed by RA administration (Thompson et al., 
1964). The degeneration of the seminiferous epithelium 
in RARa null mutants matches closely that resulting from 
a VAD diet (Lufkin et al., 1993), indicating that RA, and not 
retinol, is the active retinoid required for spermatogenesis. 
The retinol requirement likely results from the existence 
of a blood-testis barrier preventing RA delivery to the adlu- 
minal compartment of the seminiferous tubules (for refer- 
ences see Lufkin et al., 1993). The sterility of RARy mu- 
tants males, which is caused by a squamous metaplasia of 
the glandular epithelia of the prostate and seminal vesicle, 
also corresponds to a classical manifestation of the post- 
natal VAD syndrome (Lohnes et al., 1993). Thus, the reti- 
noid signal, which is necessary for spermatogenesis and 
for the maintenance of the differentiated state of the epi- 
thelia of the male accessory glands, appears to be trans- 
duced by RARa and RARy, respectively. The genital ducts 
are also severely affected in RAR compound mutant fe- 
tuses, as the oviducts, uterus, and cranial vagina are never 
formed in RARaIf32 mutants, and the vas deferens and 
seminal vesicles are agenic or severely malformed in 
RARaly mutants (Mendelsohn et al., 1994a). 
Function of RARs in Skin 
Retinoids are used to treat a variety of skin diseases, and 
RA can modulate epidermal morphogenesis in vitro (Dar- 
mon, 1991), suggesting that RA is important for skin forma- 
tion and maintenance. Expression of a dominant negative 
RAR in basal keratinocytes has resulted in an inhibition 
of epidermal differentiation, with absence of formation of 
the spinous and horny layers, and in persistent expression 
of keratin 5 and 14 in suprabasal cells(Saitou et al., 1995). 
Furthermore, expression of a dominant negative RAR in 
suprabasal keratinocytes resulted in the absence of the 
lipid lamellar structure underlying the cornified envelope, 
with a concomitent loss of barrier function (Imakado et al., 
1995). In marked contrast, RAR mutant mice have so far 
failed to reveal dramatic changes in the stratified morphol- 
ogy of the epidermis. The discrepancy between the domi- 
nant negative and the knockout results may reflect the 
presence of a low level of RARf? in RARaly double mutants 
or the interference of dominant negative RARs with other 
signaling pathways (e.g., TR, VDR, and PPAR through 
titration of RXRs; for further discussion see Andersen and 
Rosenfeld, 1995). Further studies are required to clarify 
the possible function of RARs in skin. 
Function of RXRs 
RXRs are thought to exert multiple functions in several 
signaling systems (reviewed by Mangelsdorf and Evans, 
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1995). Thus, the detection of an abnormal phenotype for 
an RXR mutant raises the question as to which of these 
pathways has been affected. Furthermore, despite the 
wealth of data dealing with the in vitro function of RX&, 
it is essentially unknown which biological processes, if 
any, are specifically regulated by 9-cis RA-liganded RXRs 
and to which extent the heterodimeric partnerships char- 
acterized in vitro operate in vivo. To date, null mutations 
for RXRa and RXRD have been engineered. 
Function of RXRa 
RXRa null mutants display a thin ventricular wall and die 
between 10.5 dpc and 17.5 dpc from cardiac failure(Sucov 
et al., 1994; Kastner et al., 1994; Dyson et al., 1995). A 
similar “spongy myocardium” phenotype has been de- 
scribed in VAD fetuses, suggesting that this ventricular 
defect reflects a role for RXRa in transducing a retinoid 
signal. However, as a milder form of spongy myocardium 
can occur in some RARaly double mutants (Mendelsohn 
et al., 1994a), the RXRa function in ventricular wall devel- 
opment may involve a heterodimeric partnership with 
RARs (see below). Early differentiated features (i.e., the 
presence of striated myofibrils) and a reduced rate of cell 
proliferation were observed in the RXRa-‘- subepicardial 
ventricular myocytes as early as 8.5 dpc. Thus, RXRa 
prevents precocious differentiation of ventricular myo- 
cytes. 
RXRa null mutants also display ocular abnormalities, 
notably malformations of the anterior segment of the eye 
and shortening of the ventral retina (Kastner et al., 1994). 
The function of RXRa in the morphogenesis of the anterior 
segment is likely to depend on a partnership with RAR;, 
as similar defects occur in RARaly and RARb2Iy double 
mutants (Figure 1), and a strong synergy for malformation 
of these structures was observed when RXRa and RARy 
mutations were combined (see below). In contrast, short- 
ening of the ventral retina is one of the few abnormalities 
of the fetal VAD syndrome that has not been found in RAR 
mutants, raising the possiblity that the function of retinoids 
in ventral retinadevelopment could be mediated by RXRa, 
independently of RARs. Interestingly, mutation of ulfraspi- 
fade (usp), the Drosophila RXR homolog, results in a 
shorter ventral retina (Oro et al., 1992), which may reflect 
a conserved function for usplRXR in eye dorsoventral pat- 
terning. That genetic mechanisms involved in eye devel- 
opment have been conserved between Drosophila and 
mouse was recently spectacularly demonstrated by the 
finding of a conserved master role of the PaxGleyeless 
gene for eye determination (Halder et al., 1995). 
Function of RXRp 
RXRP null mutants are viable and morphologically normal, 
but RXRB-‘- males are sterile owing to abnormal spermatid 
maturation and release, leading to oligo-asthenoterato- 
zoospermia (Kastner et al., 1996). The sperm abnormali- 
ties are preceded by the appearance of triglyceride drop- 
lets in Sertoli cells, which may be primarily affected since 
RXRP is present in these cells, but not in germ cells. How- 
ever, in contrast with RARa (see above), it is unlikely that 
these defects reflect a role of RXRB in mediating the reti- 
noid signal required for spermatogenesis, since testes 
from VAD mice do not accumulate lipids and degenerate 
much earlier. RXRB may rather act as an heterodimeric 
partner for PPARB, which is highly expressed in Sertoli 
cells (for reference see Kastner et al., 1996). 
Compound Mutants Suggest That RXRIRAR 
Heterodimers Are the Functional Units In Vivo 
Examination of mice deficient in RXRa and of various 
RXRalRAR mutants has revealed aconvergence between 
RXR- and RAR-dependent signaling pathways: the sever- 
ity of several ocular abnormalities present in RXRa null 
mutants increases in a graded manner with the successive 
removal of the two alleles of either RARPP or RARy (Kast- 
ner et al., 1994; Table 3); the inactivation of only one RXRa 
allele from a RARy null genetic background can cause eye 
defects identical to those observed in RXRa null mutants 
(Table 3); new abnormalities, absent in RXRa null mu- 
tants, are generated in RXRalRAR mutants (e.g., persis- 
tent truncus arteriosus in RXRa-‘-IRARa-‘- mutants; see 
Table 3). Since all of these abnormalities are present in 
VAD fetuses, these synergistic effects of RXRa and RAR 
mutations strongly suggest that, at least in some in- 
stances, RARlRXR heterodimers act as functional units 
transducing the RA signal in vivo. Thus, the analysis of 
RARlRXR double mutants may lead to the identification 
of the RARlRXR pair predominantly implicated in mediat- 
ing the RA signal in a given process. For instance, the 
complete penetrance of the persistant truncus arteriosus 
defect in RXRalRARa double null mutants, together with 
the absenceof thisdefect in RXRalRARo2 double mutants 
Table 3. Comparison of the Incidence and Severity of Malformations 
in RARlRAR and RXRulRAR Compound Mutants 
Mutations 
Defect RXRalRAR RARIRAR 
Persistent truncus 
arteriosus RXRalRARa (+++) a/1)2 (+++) 
RXRa/RARa+‘+ (+) u/y (+++) 
RXRalRARy (+) a@2+‘- (+) 
RXRa/RARy+‘+ (-) a+‘-@2 (-) 
RXRalRARb2 (-) PW (-9 
Malformations of the eye 
anterior segment RXRa” (+) U/Y (++) 
RXRa+YRARy (+) WY (++) 
RXRa/RARy+‘+ (++) 432 (-) 
RXRalRARy (+++) 
RXRu+‘-lRARP2 (-) 
RXRa/RARfi2+‘- (+) 
RXRalRARb2 (++) 
RXRa+‘-/RARa (-) 
RXRalRARu (+) 
These data show that the abnormalities that can be generated by 
either one of two compound RAR null mutations can be preferentially 
generated by a compound mutation of a specific RXRlRAR pair. Muta- 
tions are all homozygous null except where indicated. Minus indicates 
no defect. Plus to triple plus indicate either an increase of the incidence 
(persistent truncus arteriousus) or of the severity (malformations of the 
eyeanteriorsegment)ofthedefect(s). ForfurtherdetailsseeKastneret 
al. (1994). 
a In all other cases, single RXRa or RAR null mutants did not exhibit 
any abnormality. 
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and its incomplete penetrance in RXRalRARy mutants, 
strongly implicates the RXRalRARa pair is the main func- 
tional heterodimeric unit in the formation of the aorticopul- 
monary septum. That RARa plays a major role in this pro- 
cess can also be inferred from the comparison of RAR 
compound mutants (Table 3). Note that distinct RXRlRAR 
pairs may mediate the RA function in different NCC- 
dependent morphogenetic processes (aorticopulmonary 
septation and anterior eye segment development; Table 3). 
A convergence of RXR and RAR function was also sug- 
gested by Roy et al. (1995), who have shown that acombi- 
nation of limiting concentrationsof RXR-and RAR-specific 
agonists can act synergistically to activate endogenous 
RA target genes in cultured EC cells. Thus, ligand activa- 
tion of both RXR and RAR heterodimeric partners may 
be required under physiological conditions of low ligand 
levels to induce the expression of RA target genes. 
RA Excess Studies and Physiological Function of RA 
It has been widely accepted (see, for instance, the recent 
review by Means and Gudas, 1995) that the teratogenic 
effects resulting from administration of exogenous RA to 
embryos reflect a physiological role for endogenous RA 
in the corresponding developmental processes, e.g., as 
a morphogen for patterning of the limb anteroposterior 
axis. Recent genetic analyses of RAR and RXR functions 
cast some doubt on the physiological implications of RA 
excess studies. In the two instances in which an involve- 
ment of a given RAR or RXR in the mediation of a terato- 
genie event was demonstrated, the same receptor was 
clearly not required for the development of the correspond- 
ing structure during embryogenesis. This is the case for 
the RA excess-induced lumbosacral truncation that is me- 
diated by RARy (Lohnes et al., 1993) and the RA excess- 
induced limb truncations that do not occur in RXRa mu- 
tants (Sucov et al., 1995). Along the same lines, it has 
been shown that expression of a dominant negative RAR 
in Xenopus embryos could prevent RA-induced anterior 
truncations, although expression of the same mutant did 
not affect early axial patterning in the absence of addition 
of exogenous RA, which casts doubts on the presumed 
role of RA in this patterning (Smith et al., 1994). 
Functional Redundancy: What Does It Mean? 
In general, the defects generated by single knockouts of 
receptors belonging to a family (e.g., RARs, RXRs, TRs, 
PPARs, or NGFI-BINURRlINGFI-By) were milderthan ex- 
pected. As this has been extensively studied for RARs and 
RXRs, the following discussion deals with these receptors. 
The high degree of interspecies conservation of individ- 
ual RAR isoforms throughout vertebrate evolution and the 
differential distribution of their transcripts, taken together 
with molecular biology studies on RARs and RXRs, have 
suggested that the basis for the pleiotropic effect of reti- 
noids may reside in the control of different subsets of reti- 
noid-responsive promoters by cell-specifically expressed 
dimeric combinations of different RARs and RXRs (see 
Chambon, 1994). It came therefore as a surprise that sin- 
gle knockouts of given RARs or RXRs had no apparent 
effect or had much milder effects than expected. In con- 
trast, mutations affecting pairs of RARs yielded the full 
spectrum of expected defects, and in a number of cases, 
the same malformations occurred in different double mu- 
tants (Figures 1 and 2; Table 3), thus suggesting that the 
different receptors could be functionally redundant (inter- 
changeable). 
At one extreme, one could envisage that all RAR iso- 
forms, as well as all RXR isoforms are mostly, if not fully, 
functionally redundant for the transcriptional control of all 
RA target genes. The only requirement would be to reach 
a certain threshold level of RAR and RXR in a given cell 
at a given time, which could be achieved through any com- 
bination of RAR and RXR isoforms. Multiple RAR and RXR 
genes with multiple promoters and alternative splicing 
would have evolved only to fulfil these purely quantitative 
spatiotemporal requirements. For instance, the observa- 
tion that the Harderian gland is often unilaterally lacking 
in RARy mutants (Lohnes et al., 1993), whereas it is always 
bilaterally missing in RARally double mutant, may indi- 
cate that RARy and RARal are functionally redundant for 
Harderian gland ontogenesis and that, owing to stochastic 
variations of RARal levels, the critical quantitative thresh- 
old can be in some cases reached in the absence of RARy 
(for further discussion on variations of penetrance and ex- 
pressivity, see Chambon, 1994; Lohnes et al., 1994). 
In fact, it would not be surprising that, within a given 
family that has evolved by duplications from an ancestral 
gene, the various receptor isoforms may still be function- 
ally close enough to perform a number of common func- 
tions. However, studies with either RARy or RARa null F9 
EC cells have shown that the RA-induced differentiation 
of these cells and the RA inducibility of various target 
genes are differently affected by disruption of either RARa 
or RARy gene, indicating that these receptors perform 
some specific functions in these cells (Boylan et al., 1993, 
1995). Nevertheless, RARy null cells could be rescued to 
some extent by overexpression of either RARa or RARP, 
showing that RARa and RARf3 can perform some of the 
functions normally exerted by RARy, albeit with a lower 
efficiency (Taneja et al., 1995). These observations are in 
keeping with in vitro transfection studies that have shown 
that some promoters are preferentially activated by given 
receptors (Nagpal et al., 1993). 
In any event, each isoform must possess at least one 
specific function so as to explain its striking sequence 
conservation across vertebrates, particularly of its N-ter- 
minal A region, which contains a transcriptional activation 
function (AF-1) (Nagpal et al., 1993). Along these lines, it 
is interesting that chimeric receptors containing the N-ter- 
minal region of RARal or RARyl (including the DBD) 
fused to the TR LBD displayed specific functions upon Ta 
activation. In the context of regenerating newt limb blas- 
tema cells, only the RARal-TR chimera could mediate 
an inhibition of cell proliferation, whereas the RARyl-TR 
chimera specifically induced the expression of a differenti- 
ation marker(Schilthuiset al., 1993; Pecorinoetal., 1994). 
Why then are some RAR isoform mutants apparently nor- 
mal? An abnormal phenotype may not have been seen for 
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one of the following reasons: it corresponds to a discrete 
defect, which is not easily detected (e.g., a behavioral al- 
teration); it corresponds to a function dispensable in the 
laboratory (e.g., resistance to harsh climatic conditions); 
it corresponds to a function that gives a low, but significant, 
viability advantage and that cannot be detected unless 
several thousand animals are examined (see Brookfield, 
1992). 
Thus, it appears notably from studies performed with 
F9 cells that the different receptor isoforms are not truly 
functionally equivalent, even though they can substitute 
for one another under certain conditions. How can we ex- 
plain that double knockouts are often required to detect 
phenotypic abnormalities? The most likely explanation is 
that the absence of a given defect in a single mutant does 
not mean that the RA responsiveness of certain target 
genes is not impaired to some degree, but rather that the 
response mediated by the substituting receptor is still effi- 
cient enough. This is strongly supported by the observa- 
tion that there is much less functional redundancy between 
RARs in an RXRa mutant genetic background (see Table 
3). These observations can be readily accounted for by 
postulating that the actual functional units are RXRlRAR 
heterodimers. Knocking out both RXR and RAR partners 
of the specific RXRlRAR heterodimer that performs most 
efficiently a given function (e.g., RXRa and RARa in the 
case of aorticopulmonary septation) will result in the loss 
of that function, while knocking out either the RXR or the 
RAR partner only will allow functional substitution by an- 
other RXR or RAR, thus resulting in less efficient, but still 
functionally redundant, heterodimers. It will be only with 
the simultaneous mutation of RARa and either RARo2 or 
RARy that the efficiency of the remaining heterodimers 
will fall below acritical level. In other words, the conclusion 
that RARs exhibit a high degree of functional redundancy 
would be physiologically wrong because the functional 
units correspond to heterodimers, whose functional speci- 
ficity can be evaluated only by the simultaneous mutation 
of both RAR and RXR partners. Much of the RAR func- 
tional redundancy seen in knockouts would not reflect lack 
of functional specificity, but rather potentialities linked to 
the complexity of the retinoid-transducing system, which 
are revealed under the “artefactual” conditions of particu- 
lar gene knockouts. The assumption that heterodimers 
are the functional units transducing the retinoid signal also 
provides a satisfactory explanation to the otherwise puz- 
zling observation that RAR compound mutants and RXRl 
RAR mutants very often exhibit the same defects. 
Finally, functional redundancy is not the only possible 
explanation for the occurrence of a given abnormality in 
compound, but not in single mutants. More complex sce- 
narios are not excluded in which multiple molecular de- 
fects generated by nonredundant receptors, acting on 
specific subsets of RA target genes, would have to be 
combined to generate visible abnormalities (for further dis- 
cussion see Thomas, 1993; Mendelsohn et al., 1994a). 
Additional RARlRXR heterodimer knockouts, as well as 
the analysis of the expression of the corresponding RA 
target genes, are necessary to determine whether the ab- 
normalities generated by mutations of the receptors result 
from cell-autonomous or non-cell-autonomous develop- 
mental processes and ultimately to which extent any ap- 
parent phenotypic redundancy truly reflects a functional 
redundancy at the cellular and molecular levels (e.g., in 
the case of malformations of the eye anterior segments, 
which are observed in both RXRalRARy and RXRal 
RARPP compound mutants; see Figure 1 and Table 3). 
Conclusion and Perspective 
The studies summarized and discussed here illustrate the 
indispensability of loss-of-function genetic studies through 
knockouts to determine the physiological role played by 
nuclear receptors. We have learned that the simple knock- 
out of a given receptor may not result in the unambiguous 
characterization of its role in vivo, particularly when it be- 
longs to a family comprising several members and/or when 
it is a partner within a functional heterodimer. It is also 
clear that many of the presently available mutations can- 
not reveal all of the functions of a given receptor within 
the whole animal or a given organ, because they result 
in either a lethal phenotype (e.g., RXRa and HNM) or 
agenesis of that organ (e.g., gonads and adrenals in 
FTZ-Fl mutants). Obviously, the future resides in engi- 
neering mutants that are only partially deficient (e.g., in 
either one of the two activation function AF-1 and AF-2) 
and/or in creating spatiotemporally controlled knockouts 
in the animal. Clearly, these approaches, which may also 
help in identifying the human clinical symptoms associ- 
ated with mutations in nuclear receptor genes, will blos- 
som and will be limited only by the size of animal facilities! 
Finally, for many of the defects that have been observed 
to date, very little is known concerning the mechanisms 
operating at the organism, tissular, cellular, and molecular 
levels. In which cells is the primary defect(s)? What are the 
target genes affected? The present stage of description of 
the knockout-induced defects, which is mostly anatomical, 
should lead in the near future to new tissular, cellular, 
and molecular approaches making useof nuclear receptor 
mutants to explore the mechanisms underlying mamma- 
lian ontogenesis and homeostasis. 
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